Funded Tech Companies
Scinai Immunotherapeutics
Scinai Immunotherapeutics, based in Jerusalem, received equity investments from private investors.
Company Overview
Company Name
Scinai Immunotherapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Jerusalem BioPark, Hadassah Ein Kerem campus
Jerusalem, Undisclosed
Israel
Jerusalem, Undisclosed
Israel
Phone
Website
Email Address
Company Background Information
Overview
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/12/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amir Reichman
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs